An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.

Saved in:
Bibliographic Details
Title: An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.
Authors: Guerrini R; Children's Hospital A Meyer, University of Florence, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Florence, Italy., Specchio N; Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesù Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy., Aledo-Serrano Á; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain., Pringsheim M; Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik, Vogtareuth, Germany.; Department for Congenital Heart Disease and Pediatric Cardiology, German Heart Center, Munich, Germany.; Research Institute for Rehabilitation, Transition and Palliation, Paracelsus Medical University, Salzburg, Austria., Darra F; Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Verona, Italy., Mayer T; Epilepsy Center Kleinwachau, Dresden-Radeberg, Germany., Gil-Nagel A; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain., Polster T; Krankenhaus Mara - Bethel Epilepsy Centre, Department of Epileptology, Medical School, Bielefeld University, Bielefeld, Germany., Zuberi SM; Paediatric Neurosciences Research Group, Royal Hospital for Children & Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK., Lothe A; Zogenix International, Maidenhead, UK., Gammaitoni A; Zogenix, Inc., Emeryville, California, USA., Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Goethe-University Frankfurt, Frankfurt am Main, Germany.
Source: Epilepsia open [Epilepsia Open] 2022 Dec; Vol. 7 (4), pp. 578-587. Date of Electronic Publication: 2022 Aug 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101692036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9239 (Electronic) Linking ISSN: 24709239 NLM ISO Abbreviation: Epilepsia Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2470-9239
DOI:10.1002/epi4.12624